- Home
- JBI vs ORIC Comparison
JBI vs ORIC Comparison
Compare JBI & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JBI | ORIC |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 987.0M | 1.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JBI | ORIC |
|---|---|---|
| Price | $7.07 | $10.11 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 13 |
| Target Price | $10.17 | ★ $19.73 |
| AVG Volume (30 Days) | 1.0M | ★ 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.58 | N/A |
| P/E Ratio | $21.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.73 | $3.90 |
| 52 Week High | $10.80 | $14.93 |
Technical Indicators
Market Signals| Indicator | JBI | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 51.19 | 45.90 |
| Support Level | $6.57 | $9.70 |
| Resistance Level | $7.48 | $10.60 |
| Average True Range (ATR) | 0.27 | 0.78 |
| MACD | 0.01 | -0.16 |
| Stochastic Oscillator | 54.10 | 16.94 |
Price Performance
Historical ComparisonAbout JBI Janus International Group Inc.
Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.